Review: taking Marijuana and Vyvanse together


Summary

Drug interactions are reported among people who take Marijuana and Vyvanse together. This review analyzes the effectiveness and drug interactions between Marijuana and Vyvanse. It is created by eHealthMe based on reports of 36 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Marijuana and Vyvanse >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Marijuana

Marijuana has active ingredients of marijuana. It is often used in stress and anxiety. (latest outcomes from Marijuana 1,750 users)

Vyvanse

Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Vyvanse 7,909 users)

On Jul, 27, 2016

36 people who take Marijuana, Vyvanse are studied.


Number of reports submitted per year:

Marijuana and Vyvanse drug interactions.

Drug effectiveness over time:

Marijuana:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 100.0% - (3 of 3 people)
  • 6 - 12 months: 100.0% - (3 of 3 people)
  • 1 - 2 years: 40.0% - (2 of 5 people)
  • 2 - 5 years: 25.0% - (1 of 4 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 3 people)
Vyvanse:
  • < 1 month: 100.0% - (3 of 3 people)
  • 1 - 6 months: 57.0% - (4 of 7 people)
  • 6 - 12 months: 100.0% - (3 of 3 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 57.0% - (4 of 7 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Marijuana:
  • female: 50.0% - (5 of 10 people)
  • male: 45.0% - (5 of 11 people)
Vyvanse:
  • female: 66.0% - (8 of 12 people)
  • male: 80.0% - (8 of 10 people)

Drug effectiveness by age:

Marijuana:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 75.0% - (3 of 4 people)
  • 20-29: 36.0% - (4 of 11 people)
  • 30-39: 25.0% - (1 of 4 people)
  • 40-49: 100.0% - (2 of 2 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Vyvanse:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 50.0% - (2 of 4 people)
  • 20-29: 70.0% - (7 of 10 people)
  • 30-39: 83.0% - (5 of 6 people)
  • 40-49: 100.0% - (2 of 2 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • dysphagia
1 - 6 months:
  • abdominal pain
  • loss of sensation, numbness and tingling, paresthesias, sensory loss, tingling and numbness
  • abdominal bloating
  • asthma
  • dysphagia
  • headache
  • lightheadedness - fainting
  • migraine aggravated
  • muscle spasms
  • nervousness
6 - 12 months:
  • decreased appetite
  • early satiety
  • gastroparesis
  • headache
  • hives
  • swollen glands
  • swollen lymph nodes
  • vomiting
1 - 2 years:
  • abdominal pain
  • abdominal bloating
  • anxiety
  • anxiety aggravated
  • asthma
  • confusion
  • disturbance in attention
  • disturbance in social behaviour
  • dyspnoea
  • emotional distress
2 - 5 years:
  • common cold
  • fatigue
  • hallucination, visual
  • hypoglycemia
  • pain - back
  • pain - joints
  • swallowing difficulty
  • abdominal bloating
  • abdominal pain
  • anger
5 - 10 years:
  • anxiety disorder
  • depression
  • gerd
  • insomnia exacerbated
  • night sweats
  • pain exacerbated
  • ptsd
10+ years:
  • anger
  • depression aggravated
  • insomnia
not specified:
  • gait disturbance
  • loss of consciousness
  • dizziness
  • drug diversion
  • drug toxicity
  • eye disorder
  • hypokinesia
  • depression
  • drug screen positive
  • overdose

Most common drug interactions by gender *:

female:
  • gait disturbance
  • loss of consciousness
  • abdominal bloating
  • abdominal pain
  • asthma
  • dizziness
  • drug diversion
  • drug toxicity
  • eye disorder
  • hypokinesia
male:
  • depression
  • abdominal pain
  • drug screen positive
  • overdose
  • psychotic disorder
  • suicidal behaviour
  • anger
  • anxiety disorder
  • death
  • depression aggravated

Most common drug interactions by age *:

10-19:
  • abdominal pain
  • death
  • serotonin syndrome
  • sexual dysfunction
20-29:
  • abdominal bloating
  • abdominal pain
  • asthma
  • lightheadedness - fainting
  • migraine aggravated
  • muscle spasms
  • nervousness
  • numbness in hands or feet
  • scoliosis
  • anger
30-39:
  • depression
  • drug screen positive
  • overdose
  • psychotic disorder
  • suicidal behaviour
  • common cold
  • fatigue
  • hypoglycemia
  • insomnia
  • loss of sensation, numbness and tingling, paresthesias, sensory loss, tingling and numbness
40-49:
  • decreased appetite
  • early satiety
  • gastroparesis
  • vomiting

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Marijuana and Vyvanse?


Recent conversations of related support groups:

Can you answer these questions?

More questions for: Marijuana, Vyvanse

You may be interested in these reviews

More reviews for: Marijuana, Vyvanse

On eHealthMe, Marijuana (marijuana) is often used to treat stress and anxiety. Vyvanse (lisdexamfetamine dimesylate) is often used to treat attention deficit hyperactivity disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.